Neptune Wellness Solutions Inc (NASDAQ: NEPT) stock jumped 25.15% on Monday to $0.85 against a previous-day closing price of $0.68. With 12.0 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.65 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.9300 whereas the lowest price it dropped to was $0.7400. The 52-week range on NEPT shows that it touched its highest point at $41.60 and its lowest point at $0.62 during that stretch. It currently has a 1-year price target of $877.67. Beta for the stock currently stands at 2.28.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEPT was up-trending over the past week, with a rise of 26.82%, but this was up by 3.66% over a month. Three-month performance dropped to -90.42% while six-month performance fell -90.63%. The stock lost -97.83% in the past year, while it has lost -93.26% so far this year.
Float and Shares Shorts:
At present, 12.00 million NEPT shares are outstanding with a float of 7.36 million shares on hand for trading. On Oct 30, 2023, short shares totaled 39760.0, which was 4.66% higher than short shares on Sep 28, 2023. In addition to Mr. Michael Cammarata as the firm’s President, CEO & Director, Mr. John S. Wirt serves as its Chief Legal Officer, Executive VP of Legal & Business Affairs and General Counsel.
Institutional Ownership:
Other institutions hold 23.34% of NEPT, in contrast to 0.17% held by mutual funds. As the largest shareholder in NEPT with 21.91% of the stake, Sabby Management LLC holds 186,890 shares worth 186,890. A second-largest stockholder of NEPT, UBS Securities LLC, holds 7,398 shares, controlling over 0.87% of the firm’s shares. JPMorgan Asset Management is the third largest shareholder in NEPT, holding 3,976 shares or 0.47% stake. With a 0.14% stake in NEPT, the Amplify Seymour Cannabis ETF is the largest stakeholder. A total of 1,210 shares are owned by the mutual fund manager. The SPDR S&P International Small Cap, which owns about 0.03% of NEPT stock, is the second-largest Mutual Fund holder. It holds 224 shares valued at 161.0. Fidelity Nasdaq Composite Index F holds 0.00% of the stake in NEPT, owning 0 shares worth 0.0.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEPT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NEPT analysts setting a high price target of $877.67 and a low target of $877.67, the average target price over the next 12 months is $877.67. Based on these targets, NEPT could surge 103155.29% to reach the target high and rise by 103155.29% to reach the target low. Reaching the average price target will result in a growth of 103155.29% from current levels.
Dividends & Yield:
In terms of dividends, NEPT has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and NEPT currently yields $––. In the past year, NEPT’s dividend yield has been $––, but when looking at the stock over the past five years, its yield has been $––. Accordingly, NEPT has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.
Summary of Insider Activity:
Insiders traded NEPT stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has risen to 1 over the past year. The total number of shares bought during that period was 140,230 while 34,348 shares were sold.
